Minaris Regenerative Medicine GmbH (formerly apceth Biopharma GmbH)

General information

Minaris Regenerative Medicine GmbH (formerly apceth Biopharma GmbH)
Haidgraben 5
85521 Ottobrunn, Bavaria
Germany

Contact person: Dusan Kosijer, Managing Director
Company main phone: +49 (89) 70096080
Website: https://www.rm.minaris.com

Year founded:	2007
Source of foundation:	Independent foundation

Corporate description / mission:
Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. The company offers high value clinical and commercial manufacturing services, development solutions, and technologies. Facilities in the US, Europe, and Asia allow supplying patients worldwide with life-changing therapies.

State of ownership: Subsidiary
Headquarters: No

Remarks on ownership / listings
Minaris Regenerative Medicine GmbH is a Showa Denko Materials Co. Ltd. group company.
The company changed the name from apceth Biopharma GmbH in September 2020.

Categorization

Sector:

Biotechnology - R&D Services

Subsector:

CMO (Contract Manufacturing Organization)

Business model:

Manufacturer
R&D
Service company
Subsidiary
Supplier / Distributor

Customer segments:

Other
Hospitals
Large biotech & big pharma
Small biotech

Distribution:

Direct (own sales force)

Summary Products / Services / Technologies

Description of products:
GMP services fact sheet
Quality management
Quality control
Assay development
GMP manufacturing
Process development
EU import & export
Cell banking & formulation
Project management, etc.